Q08879 (FBLN1_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 133.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Fibulin-1 Short name=FIBL-1 Alternative name(s): Basement-membrane protein 90 Short name=BM-90 | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 705 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Incorporated into fibronectin-containing matrix fibers. May play a role in cell adhesion and migration along protein fibers within the extracellular matrix (ECM). Could be important for certain developmental processes and contribute to the supramolecular organization of ECM architecture, in particular to those of basement membranes. |
| Subunit structure | Homomultimerizes and interacts with various extracellular matrix components such as FN1, LAMA1, LMA2, NID, ACAN, CSPG2 and type IV collagen. Interacts also with papillomavirus E6 proteins. Binding analysis demonstrated for isoform C a 100-fold stronger binding to the basement membrane protein NID than for isoform D. Interacts with FBLN7. Ref.1 Ref.9 Ref.10 Ref.11 Ref.14 Ref.16 |
| Subcellular location | |
| Tissue specificity | Detected in most organs (brain, heart, lung, spleen, liver and kidney). Neurons are the predominant source of production in the brain. Not expressed significantly by astrocytes or microglia. Ref.13 |
| Developmental stage | The differential expression of the fibulin family contributes to the formation of molecularly distinct extracellular matrices already during early developmental stages of a large number of tissues. Increase expression at neonate stage in the brain. Expressed in interdigital regions of the handplate of a 12 dpc embryo and in the lateral perichondrial region. Similar expression persists in the 13 dpc handplate particularly in the perichondrial regions and apical aspects of the developing digits. Ref.7 Ref.13 Ref.15 |
| Induction | Glucocorticoids suppressed mRNA expression and protein synthesis. Ref.12 |
| Sequence similarities | Belongs to the fibulin family. Contains 3 anaphylatoxin-like domains. Contains 9 EGF-like domains. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Extracellular matrix Secreted |
| Coding sequence diversity | Alternative splicing |
| Domain | EGF-like domain Repeat Signal |
| Ligand | Calcium |
| PTM | Disulfide bond Glycoprotein |
| Technical term | Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | embryo implantation Inferred from electronic annotation. Source: Compara extracellular matrix organizationInferred from direct assay PubMed 18757743. Source: MGI |
| Cellular_component | basement membrane Inferred from direct assay PubMed 16061471. Source: MGI extracellular spaceInferred from electronic annotation. Source: Compara |
| Molecular_function | calcium ion binding Inferred from electronic annotation. Source: InterPro peptidase activator activityInferred from direct assay PubMed 16061471. Source: MGI |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform D (identifier: Q08879-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform A (identifier: Q08879-3) The sequence of this isoform is not available. | ||||||
| Isoform B (identifier: Q08879-4) The sequence of this isoform is not available. | ||||||
| Isoform C (identifier: Q08879-2) The sequence of this isoform differs from the canonical sequence as follows: 569-705: FRQEKTDTVR...VHIFVSEYWF → RCERLPCHEN...KLFIFVSAEL |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 29 | 29 | Ref.5 | ||||||||
| Chain | 30 – 705 | 676 | Fibulin-1 | PRO_0000007564 | |||||||
Regions | |||||||||||
| Domain | 36 – 76 | 41 | Anaphylatoxin-like 1 | ||||||||
| Domain | 77 – 111 | 35 | Anaphylatoxin-like 2 | ||||||||
| Domain | 112 – 144 | 33 | Anaphylatoxin-like 3 | ||||||||
| Domain | 178 – 217 | 40 | EGF-like 1 | ||||||||
| Domain | 218 – 263 | 46 | EGF-like 2; calcium-binding Potential | ||||||||
| Domain | 264 – 309 | 46 | EGF-like 3; calcium-binding Potential | ||||||||
| Domain | 310 – 357 | 48 | EGF-like 4; calcium-binding Potential | ||||||||
| Domain | 358 – 400 | 43 | EGF-like 5; calcium-binding Potential | ||||||||
| Domain | 401 – 442 | 42 | EGF-like 6; calcium-binding Potential | ||||||||
| Domain | 443 – 482 | 40 | EGF-like 7; calcium-binding Potential | ||||||||
| Domain | 483 – 526 | 44 | EGF-like 8; calcium-binding Potential | ||||||||
| Domain | 527 – 580 | 54 | EGF-like 9; calcium-binding Potential | ||||||||
| Region | 358 – 442 | 85 | Self-association and FN1-binding By similarity | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 98 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 537 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 541 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 36 ↔ 61 | By similarity | |||||||||
| Disulfide bond | 37 ↔ 68 | By similarity | |||||||||
| Disulfide bond | 50 ↔ 69 | By similarity | |||||||||
| Disulfide bond | 78 ↔ 109 | By similarity | |||||||||
| Disulfide bond | 91 ↔ 110 | By similarity | |||||||||
| Disulfide bond | 112 ↔ 136 | By similarity | |||||||||
| Disulfide bond | 113 ↔ 143 | By similarity | |||||||||
| Disulfide bond | 126 ↔ 144 | By similarity | |||||||||
| Disulfide bond | 182 ↔ 192 | By similarity | |||||||||
| Disulfide bond | 188 ↔ 201 | By similarity | |||||||||
| Disulfide bond | 203 ↔ 216 | By similarity | |||||||||
| Disulfide bond | 222 ↔ 235 | By similarity | |||||||||
| Disulfide bond | 229 ↔ 244 | By similarity | |||||||||
| Disulfide bond | 250 ↔ 262 | By similarity | |||||||||
| Disulfide bond | 268 ↔ 281 | By similarity | |||||||||
| Disulfide bond | 275 ↔ 290 | By similarity | |||||||||
| Disulfide bond | 296 ↔ 308 | By similarity | |||||||||
| Disulfide bond | 314 ↔ 327 | By similarity | |||||||||
| Disulfide bond | 321 ↔ 336 | By similarity | |||||||||
| Disulfide bond | 343 ↔ 356 | By similarity | |||||||||
| Disulfide bond | 362 ↔ 375 | By similarity | |||||||||
| Disulfide bond | 369 ↔ 384 | By similarity | |||||||||
| Disulfide bond | 386 ↔ 399 | By similarity | |||||||||
| Disulfide bond | 405 ↔ 417 | By similarity | |||||||||
| Disulfide bond | 413 ↔ 426 | By similarity | |||||||||
| Disulfide bond | 428 ↔ 441 | By similarity | |||||||||
| Disulfide bond | 447 ↔ 456 | By similarity | |||||||||
| Disulfide bond | 452 ↔ 465 | By similarity | |||||||||
| Disulfide bond | 467 ↔ 481 | By similarity | |||||||||
| Disulfide bond | 487 ↔ 500 | By similarity | |||||||||
| Disulfide bond | 496 ↔ 509 | By similarity | |||||||||
| Disulfide bond | 511 ↔ 525 | By similarity | |||||||||
| Disulfide bond | 531 ↔ 544 | By similarity | |||||||||
| Disulfide bond | 538 ↔ 553 | By similarity | |||||||||
| Disulfide bond | 558 ↔ 579 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 569 – 705 | 137 | FRQEK…SEYWF → RCERLPCHENQECPRLPLRI TYYHLSFPTNIQVPAVVFRM GPSSAVPGDSMQLAITAGNE EGFFTTRKVSHHSGVVALTK PIPEPRDLLLTVKMDLYRHG TVSSFVAKLFIFVSAEL in isoform C. | VSP_001386 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 30 | 1 | D → N AA sequence Ref.5 | ||||||||
| Sequence conflict | 40 | 1 | G → P in CAA50207. Ref.1 | ||||||||
| Sequence conflict | 363 | 1 | S → A in CAA50207. Ref.1 | ||||||||
| Sequence conflict | 385 | 1 | E → K in BAC39669. Ref.2 | ||||||||
| Sequence conflict | 553 | 1 | C → Q AA sequence Ref.5 | ||||||||
| Sequence conflict | 558 | 1 | C → Q AA sequence Ref.5 | ||||||||
| Isoform C: | |||||||||||
| Sequence conflict | 571 | 1 | E → A in CAA50206. Ref.1 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands." Pan T.-C., Kluge M., Zhang R.Z., Mayer U., Timpl R., Chu M.-L. Eur. J. Biochem. 215:733-740(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS C AND D), LIGANDS INTERACTION. |
| [2] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C). Strain: C57BL/6J. Tissue: Head and Urinary bladder. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C). Tissue: Mammary tumor. |
| [4] | "Structural and functional characterization of the human and mouse fibulin-1 gene promoters: role of Sp1 and Sp3." Castoldi M., Chu M.-L. Biochem. J. 362:41-50(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-26. |
| [5] | "Characterization of a novel calcium-binding 90-kDa glycoprotein (BM-90) shared by basement membranes and serum." Kluge M., Mann K., Dziadek M., Timpl R. Eur. J. Biochem. 193:651-659(1990) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 30-53; 110-117; 231-243; 339-387; 434-439; 469-476; 553-563 AND 574-581. |
| [6] | "Structural characterization of two variants of fibulin-1 that differ in nidogen affinity." Sasaki T., Kostka G., Goehring W., Wiedemann H., Mann K., Chu M.-L., Timpl R. J. Mol. Biol. 245:241-250(1995) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF NID AFFINITY. |
| [7] | "Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo." Zhang H.-Y., Timpl R., Sasaki T., Chu M.-L., Ekblom P. Dev. Dyn. 205:348-364(1996) [PubMed] [Europe PMC] [Abstract] Cited for: DEVELOPMENTAL STAGE. |
| [8] | "Binding of fibulin-1 to nidogen depends on its C-terminal globular domain and a specific array of calcium-binding epidermal growth factor-like (EG) modules." Adam S., Goehring W., Wiedemann H., Chu M.-L., Timpl R., Kostka G. J. Mol. Biol. 272:226-236(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NID-BINDING SITE. Strain: 129/Sv. |
| [9] | "Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins." Talts J.F., Andac Z., Goehring W., Brancaccio A., Timpl R. EMBO J. 18:863-870(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH LAMA2. |
| [10] | "Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican." Aspberg A., Adam S., Kostka G., Timpl R., Heinegaard D. J. Biol. Chem. 274:20444-20449(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ACAN AND CSPG2. |
| [11] | "Recombinant domains of mouse nidogen-1 and their binding to basement membrane proteins and monoclonal antibodies." Ries A., Goehring W., Fox J.W., Timpl R., Sasaki T. Eur. J. Biochem. 268:5119-5128(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH NID. |
| [12] | "Glucocorticoids down-regulate the extracellular matrix proteins fibronectin, fibulin-1 and fibulin-2 in bone marrow stroma." Gu Y.-C., Talts J.F., Gullberg D., Timpl R., Ekblom M. Eur. J. Haematol. 67:176-184(2001) [PubMed] [Europe PMC] [Abstract] Cited for: DOWN-REGULATION BY GLUCOCORTICOIDS. |
| [13] | "Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function." Ohsawa I., Takamura C., Kohsaka S. J. Neurochem. 76:1411-1420(2001) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| [14] | "Interaction of oncogenic papillomavirus E6 proteins with fibulin-1." Du M., Fan X., Hong E., Chen J.J. Biochem. Biophys. Res. Commun. 296:962-969(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH E6, INHIBITION OF E6-MEDIATED TRANSFORMATION. |
| [15] | "The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly." Debeer P., Schoenmakers E.F.P.M., Twal W.O., Argraves W.S., De Smet L., Fryns J.-P., Van De Ven W.J.M. J. Med. Genet. 39:98-104(2002) [PubMed] [Europe PMC] [Abstract] Cited for: DEVELOPMENTAL STAGE. |
| [16] | "TM14 is a new member of the fibulin family (fibulin-7) that interacts with extracellular matrix molecules and is active for cell binding." de Vega S., Iwamoto T., Nakamura T., Hozumi K., McKnight D.A., Fisher L.W., Fukumoto S., Yamada Y. J. Biol. Chem. 282:30878-30888(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FBLN7. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | X70854 mRNA. Translation: CAA50207.1. X70853 mRNA. Translation: CAA50206.1. AK086451 mRNA. Translation: BAC39669.1. AK035388 mRNA. Translation: BAC29054.1. BC007140 mRNA. Translation: AAH07140.1. AY040588 Genomic DNA. Translation: AAK82944.1. |
| IPI | IPI00230432. IPI00322748. |
| PIR | S34968. S78040. |
| RefSeq | NP_034310.2. NM_010180.2. |
| UniGene | Mm.297992. |
3D structure databases | |
| ProteinModelPortal | Q08879. |
| SMR | Q08879. Positions 186-564. |
| ModBase | Search... |
Protein-protein interaction databases | |
| MINT | MINT-245863. |
PTM databases | |
| PhosphoSite | Q08879. |
Proteomic databases | |
| PaxDb | Q08879. |
| PRIDE | Q08879. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000057410; ENSMUSP00000054583; ENSMUSG00000006369. ENSMUST00000109432; ENSMUSP00000105058; ENSMUSG00000006369. |
| GeneID | 14114. |
| KEGG | mmu:14114. |
| UCSC | uc007xdb.2. mouse. |
Organism-specific databases | |
| CTD | 2192. |
| MGI | MGI:95487. Fbln1. |
Phylogenomic databases | |
| eggNOG | NOG12793. |
| GeneTree | ENSGT00700000104154. |
| HOGENOM | HOG000007079. |
| HOVERGEN | HBG051559. |
| InParanoid | Q08879. |
| OMA | MDSATEQ. |
| OrthoDB | EOG4NGGM2. |
Gene expression databases | |
| ArrayExpress | Q08879. |
| Bgee | Q08879. |
| CleanEx | MM_FBLN1. |
| Genevestigator | Q08879. |
| GermOnline | ENSMUSG00000006369. Mus musculus. |
Family and domain databases | |
| InterPro | IPR000020. Anaphylatoxin/fibulin. IPR026823. cEGF. IPR000742. EG-like_dom. IPR001881. EGF-like_Ca-bd. IPR013032. EGF-like_CS. IPR000152. EGF-type_Asp/Asn_hydroxyl_site. IPR018097. EGF_Ca-bd_CS. IPR017048. Fibulin-1. [Graphical view] |
| Pfam | PF01821. ANATO. 2 hits. PF12662. cEGF. 3 hits. PF07645. EGF_CA. 4 hits. [Graphical view] |
| PIRSF | PIRSF036313. Fibulin-1. 1 hit. |
| SMART | SM00104. ANATO. 3 hits. SM00181. EGF. 2 hits. SM00179. EGF_CA. 7 hits. [Graphical view] |
| PROSITE | PS01177. ANAPHYLATOXIN_1. 3 hits. PS01178. ANAPHYLATOXIN_2. 3 hits. PS00010. ASX_HYDROXYL. 4 hits. PS00022. EGF_1. False negative. PS01186. EGF_2. 3 hits. PS50026. EGF_3. 4 hits. PS01187. EGF_CA. 8 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | FBLN1. mouse. |
| NextBio | 285170. |
| SOURCE | Search... |
Entry information
| Entry name | FBLN1_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q08879 Secondary accession number(s): Q08878 Q922K8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
